Puma Biotechnology Inc (PBYI) - Financial and Strategic SWOT Analysis Review
SKU ID :GD-12879845 | Published Date: 20-Dec-2018 | No. of pages: 46Description
TOC
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Puma Biotechnology Inc - Key Facts 5
Puma Biotechnology Inc - Key Employees 6
Puma Biotechnology Inc - Key Employee Biographies 7
Puma Biotechnology Inc - Major Products and Services 8
Puma Biotechnology Inc - History 9
Puma Biotechnology Inc - Company Statement 10
Puma Biotechnology Inc - Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 – Company Analysis 12
Company Overview 12
Puma Biotechnology Inc - Business Description 13
Puma Biotechnology Inc - Corporate Strategy 14
Puma Biotechnology Inc - SWOT Analysis 15
SWOT Analysis - Overview 15
Puma Biotechnology Inc - Strengths 15
Puma Biotechnology Inc - Weaknesses 16
Puma Biotechnology Inc - Opportunities 17
Puma Biotechnology Inc - Threats 18
Puma Biotechnology Inc - Key Competitors 19
Section 3 – Company Financial Ratios 20
Financial Ratios - Capital Market Ratios 20
Financial Ratios - Annual Ratios 21
Performance Chart 23
Financial Performance 23
Financial Ratios - Interim Ratios 24
Financial Ratios - Ratio Charts 25
Section 4 – Company’s Lifesciences Financial Deals and Alliances 26
Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26
Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27
Puma Biotechnology Inc, Recent Deals Summary 28
Section 5 – Company’s Recent Developments 29
Aug 09, 2018: Puma Biotechnology reports second quarter 2018 financial results 29
May 09, 2018: Puma Biotechnology Reports First Quarter 2018 Financial Results 31
Dec 14, 2017: Puma Biotechnology Added to NASDAQ Biotechnology Index 33
Nov 09, 2017: Puma Biotechnology Reports Third Quarter 2017 Financial Results 34
Nov 02, 2017: Puma Biotechnology Secures $100 Million Term Loan from Oxford Finance and Silicon Valley Bank 35
Aug 09, 2017: Puma Biotechnology Reports Second Quarter 2017 Financial Results 36
May 10, 2017: Puma Biotechnology Reports First Quarter 2017 Financial Results 38
Mar 01, 2017: Puma Biotechnology Reports Fourth Quarter and Full Year 2016 Financial Results 40
Section 6 – Appendix 42
Methodology 42
Ratio Definitions 42
About GlobalData 46
Contact Us 46
Disclaimer 46
Tables & Figures
List of Tables
Puma Biotechnology Inc, Key Facts 5
Puma Biotechnology Inc, Key Employees 6
Puma Biotechnology Inc, Key Employee Biographies 7
Puma Biotechnology Inc, Major Products and Services 8
Puma Biotechnology Inc, History 9
Puma Biotechnology Inc, Subsidiaries 11
Puma Biotechnology Inc, Key Competitors 19
Puma Biotechnology Inc, Ratios based on current share price 20
Puma Biotechnology Inc, Annual Ratios 21
Puma Biotechnology Inc, Annual Ratios (Cont...1) 22
Puma Biotechnology Inc, Interim Ratios 24
Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26
Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27
Puma Biotechnology Inc, Recent Deals Summary 28
Currency Codes 42
Capital Market Ratios 42
Equity Ratios 43
Profitability Ratios 43
Cost Ratios 44
Liquidity Ratios 44
Leverage Ratios 45
Efficiency Ratios 45List of Figures
Puma Biotechnology Inc, Performance Chart (2013 - 2017) 23
Puma Biotechnology Inc, Ratio Charts 25
Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26
Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 27
Companies
Five Prime Therapeutics Inc
Fate Therapeutics Inc
Corcept Therapeutics Inc
Cascadian Therapeutics Inc
Ayala Pharmaceuticals Inc
- PRICE
-
$125$375